XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues $ 25,797 $ 19,960 $ 75,063 $ 59,711
Cost of revenues:        
Total cost of revenues 10,525 9,249 30,583 26,145
Gross profit 15,272 10,711 44,480 33,566
Operating expenses:        
Research and development 17,019 10,353 47,376 28,322
Sales and marketing 3,969 5,185 13,120 15,621
General and administrative 9,729 6,465 28,316 20,491
Total operating expenses 30,717 22,003 88,812 64,434
Loss from operations (15,445) (11,292) (44,332) (30,868)
Other income:        
Gain on equity investments     4,156  
Change in fair value 18,233 (1,427) 23,513 10,607
Interest income 463 501 1,732 1,463
Total other income (loss) 18,696 (926) 29,401 12,070
Income (loss) before income taxes 3,251 (12,218) (14,931) (18,798)
Income tax (benefit) expense (35) (257) 120 (262)
Net income (loss) 3,286 (11,961) (15,051) (18,536)
Net loss attributable to noncontrolling interest (566) (453) (1,727) (734)
Net income (loss) attributable to Schrödinger common and limited common stockholders $ 3,852 $ (11,508) $ (13,324) $ (17,802)
Net income (loss) per share attributable to Schrödinger common and limited common stockholders, basic: $ 0.06 $ (0.26) $ (0.23) $ (0.40)
Weighted average shares used to compute net income (loss) per share attributable to Schrödinger common and limited common stockholders, basic: 66,339,570 44,879,188 56,802,567 44,623,383
Net income (loss) per share attributable to Schrödinger common and limited common stockholders, diluted: $ 0.05 $ (0.26) $ (0.23) $ (0.40)
Weighted average shares used to compute net income (loss) per share attributable to Schrödinger common and limited common stockholders, diluted: 72,693,173 44,879,188 56,802,567 44,623,383
Software Products and Services        
Revenues:        
Total revenues $ 22,861 $ 16,118 $ 67,573 $ 49,205
Cost of revenues:        
Total cost of revenues 4,334 3,097 12,197 9,901
Drug Discovery        
Revenues:        
Total revenues 2,936 3,842 7,490 10,506
Cost of revenues:        
Total cost of revenues $ 6,191 $ 6,152 $ 18,386 $ 16,244